Loop Genomics is a pioneering biotechnology and information technology company founded in 2015 and headquartered in the United States. The company's mission is reflected in its slogan: "long-read service and library prep kits for Microbiome, Transcriptome, and PCR Amplicon sequencing." Loop Genomics stands out with its innovative, hardware-free synthetic long-read sequencing approach. This groundbreaking technology effectively transforms any short-read sequencer into a single molecule long-read sequencer. The company has developed proprietary sample prep and software that tag DNA/RNA molecules with DNA barcodes and copies and pastes those barcodes intra-molecularly throughout long molecules. Following this process, the libraries are converted into a standard short-read library and sequenced on any short-read sequencer. Once the sequencing is complete, reads with the same barcodes are grouped together and reassembled back into the longer molecules that were tagged by those barcodes using Loop's software. Loop sequencing is employed to assemble genomes, transcriptomes, or targeted amplicons from long reads, delivering highly accurate, single molecule long-read data for any application while leveraging existing short-read infrastructure. The company's innovative and transformative approach has garnered notable recognition in the industry, including a recent Venture Round investment at 01 January 2021 by Page One Ventures. In summary, Loop Genomics's pioneering technology and recent investment indicate its potential for significant impact and growth in the field of genomic sequencing and analysis.